http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103524398-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F5-027 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D209-80 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D209-80 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F5-02 |
filingDate | 2013-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2016-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2016-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-103524398-B |
titleOfInvention | Based on high condensed ring one azepine [6] helicene compound and the synthetic method thereof of naphthalene |
abstract | The invention provides a kind of high condensed ring one azepine [6] helicene compound (I) based on naphthalene and synthetic method thereof, belong to chemical technology field.The present invention for raw material, adopts the method for photochemical catalysis closed loop with naphthalene and carbazole derivative, and successfully an obtained class has high condensed ring one azepine [6] the helicene compound of photoelectric functional.The present invention has that productive rate is high, the time is short, simple operation and other advantages, and uses the reagent of conventional low cost, reduces the cost of preparation, is easy to apply.High condensed ring one azepine [6] helicene compound (I) based on naphthalene has good solvability in different organic solvents, is conducive to the purification of this compound, masking; Multiple high condensed ring one azepine [6] helicene compound can be obtained by access different substituents.High condensed ring one azepine [6] helicene compound (I) based on naphthalene is expected to be used widely in fields such as organic electroluminescent, organic field-effect tube, organic second-order non-linear, chiral liquid crystal and biological medicines. |
priorityDate | 2013-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 61.